Indications And Dose
Raised intra-ocular pressure in open-angle glaucoma | Ocular hypertension ▶TO THE EYE ▶Adult: Apply once daily, to be administered preferably in the evening
PDF page 1270
Loading InternPractice…
Drug reference
Raised intra-ocular pressure in open-angle glaucoma | Ocular hypertension ▶TO THE EYE ▶Adult: Apply once daily, to be administered preferably in the evening
PDF page 1270
Angle-closure glaucoma (no experience of use) . aphakia. asthma. congenital glaucoma (no experience of use). contact lens wearers. inflammatory ocular conditions (no experience of use). narrow-angle glaucoma (no experience of use). neovascular glaucoma (no experience of use). pseudophakia with torn posterior lens capsule or anterior chamber lenses. risk factors for cystoid macular oedema. risk factors for iritis. risk factors for uveitis
PDF page 1270
Although multi-dose tafluprost eye drops commonly contain preservatives, preservative-free unit dose vials may be available.
PDF page 1270
▶Common or very common Dry eye. eye discolouration. eye discomfort. eye disorders. eye inflammation. headache. vision disorders ▶Uncommon Hypertrichosis ▶Frequency not known Asthma exacerbated. dyspnoea
PDF page 1270
Manufacturer advises avoid unless potential benefit outweighs risk—toxicity in animal studies.
PDF page 1270
Manufacturer advises avoid—present in milk in animal studies.
PDF page 1270
Manufacturer advises caution (no information available).
PDF page 1270
Use with caution—no information available.
PDF page 1270
There can be variation in the licensing of different medicines containing the same drug. Eye drops EXCIPIENTS: May contain Disodium edetate ▶Saflutan (Santen UK Ltd) Tafluprost 15 microgram per 1 ml Saflutan 15micrograms/ml eye drops | 3 ml P £11.39 Saflutan 15micrograms/ml eye drops 0.3ml unit dose | 30 unit dose P £12.20 DT = £12.20
PDF page 1271
Changes to eye colour Before initiating treatment, patients should be warned of a possible change in eye colour as an increase in the brown pigment in the iris can occur, which may be permanent; particular care is required in those with mixed coloured irides and those receiving treatment to one eye only. Changes in eyelashes and vellus hair can also occur, and patients should also be advised to avoid repeated contact of the eye drop solution with skin as this can lead to hair growth or skin pigmentation.
PDF page 1270
Apply once daily, to be administered preferably
First-line fragment. Read the complete Indications and Dose section above.
PDF page 1270